Oncology Virtual Partnering: 2-5 March, 2021
During four days of face to face online meetings, leading researchers, top biotechs and biopharmaceutical companies will meet, network and partner to accelerate oncology pipelines and bring new treatment options to patients worldwide.
About this conference
Find the best early-stage biotechs
Oncology is one of the most challenging areas for research and development, but there are critical junctures where the right environment is crucial for success - and where partnering can help bring the best science forward.
At Inova, our aim is to facilitate the bridge between science and business. Inova and Biotechnology Innovation Organization (BIO), in partnership with Evaluate, are organizing this Oncology Virtual Partnering Event. Through online one-to-one meetings taking place 2 - 5 March, researchers, biotechs and biopharmaceutical companies will discuss the latest research from oncology congresses, pitch ideas and partner to prioritize the most promising research efforts.
This event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide.
Calculating Risk and Return in Oncology Development Webinar
9AM — 10 am (ET) / 3 pm — 4 pm (CET)
What is a virtual Partnering Event?
It’s a conference of virtual face-to-face meetings. All meetings are online instead of at a physical location.
Increase your company visibility during the event
Free Company Presentations
If you are an attending biotech, biopharma, medtech or digital health company, you benefit from free visibility with a company presentation (max. 6 minutes video or PDF slideshow).
Submit a presentationLive Sessions
Can’t make it to a live session? Register anyway and we will send your the recording.
Webinar recording
Events Preview & Platform Demo Webinar
10AM — 11 am (ET) / 4 pm — 5 pm (CET)
Get an insider’s preview of Inova & BIO’s upcoming Virtual Partnering events in March: Oncology Virtual Partnering 2-5 March and Immunology Virtual Partnering 9-12 March
Our team from Inova, BIO and Evaluate will animate a live session on:
- Who’s attending: company and asset profiles
- A walk-through of Inova’s best-in-class One-on-One Partnering™ platform
- The ins & outs of Virtual Partnering and how to make the most of the event
- Webinar sessions during the events
- Q&A
Who will attend?
The Oncology Virtual Partnering Event is open to any organization that provides product, knowledge or technologies that can help advance the oncology pipeline. The types of treatments being developed range from chemotherapy, small molecules and oral drug formulations all the way to cancer vaccines, immune cell therapies, cytokine modulation and monoclonal antibodies.
Pharma & Biotech
Academia
Medical Research
Services
Clinical Trials
Diagnostic & Biomarkers
Carrier Systems & Formulation
Financing
The Virtual Partnering Event will bring these stakeholders together to pursue:
Timeline
Registration for the Oncology Virtual Partnering event opens on 18 January. Then, our partnering platform, One-on-One Partnering, will open on 15 February so that participants will have a little over 3 weeks to make connections and request online meetings. On 2 March the virtual partnering starts with online scheduled meetings for four days through 5 March.
18 January 2021
Registration opens
Registration for the Virtual
Partnering Event starts.
15 February 2021
Platform is open
Participants can begin
sending meeting requests.
2-5 March 2021
Virtual Conference
Scheduled meetings will
take place online.
About the Virtual Partnering Platform
This event will leverage Inova and BIO's matchmaking platform, One-on-One Partnering™, that has been at the heart of major international biopharmaceutical conventions since 2015. It’s the leading partnering system that facilitates thousands of face-to-face meetings at dozens of biopharma conferences worldwide including the BIO International Convention, BIO Digital and BIO Asia. For instance, in the weeks before the BIO International Convention, 4,000 biopharma companies connect online, list their technologies and capabilities, and request meetings with potential partners. By the time the Convention opens thousands of relevant meetings are scheduled – almost 50,000 at BIO Convention 2019 alone.